Central nervous system distribution kinetics of indinavir in rats

Journal of Pharmacy and Pharmacology

Volumn 59, Issue 8, 2007, Pages 1077-1085

  Hamidi, Mehrdad ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; KINETICS; MALE; NONHUMAN; RAT;

ANIMALS; AREA UNDER CURVE; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CENTRAL NERVOUS SYSTEM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HIV PROTEASE INHIBITORS; INDINAVIR; INJECTIONS, INTRAVENOUS; MALE; MODELS, BIOLOGICAL; PERMEABILITY; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 34547933529     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.59.8.0004     Document Type: Article

References (47)

1. Abraham, M. H., Platts, J. A. (2000) Physicochemical factors that influence brain uptake. In: Begley, D. J., Bradbury, M. W., Kreuter, J. (eds) Blood-brain barrier and drug delivery to the CNS. Marcel Dekker Inc., New York, pp 9-32
2. Acosta, E. P., Henry, K., Baken, L., Page, L. M., Fletcher, C. V. (1999) Indinavir concentrations and antiviral effect. Pharmacotherapy 19: 708-712
3. Anderson, B. D., Hoesterey, B. L., Baker, D. C., Galinsky, R. E. (1990) Uptake kinetics of 2′,3′-dideoxyinosine into brain and cerebrospinal fluid of rats: intravenous infusion studies. J. Pharmacol. Exp. Ther. 253: 113-118
4. Bereczki, D., Wei, L., Acuff, V., Gruber, K., Tajima, A., Patlak, C., Fenstermacher, J. (1992) Technique-dependent variations in cerebral microvessel blood volumes and hematocrits in the rat. J. Appl. Physiol. 73: 918-924
5. Chiba, M., Hensleigh, M., Lin, J. H. (1997) Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes. Major role of CYP3A. Biochem. Pharmacol. 53: 1187-1195
6. Chiba, M., Nishime, J. A., Neway, Y., Lin, Y., Lin, J. H. (2000) Comparative in vitro metabolism of indinavir in primates - a unique stereoselective hydroxylation in monkey. Xenobiotica 30: 117-129
7. Choo, E. F., Leake, B., Wandel, C., Imamura, H., Wood, A. J., Wilkinson, G. R., Kim, R. B. (2000) Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testis. Drug. Metab. Dispos. 28: 655-660
8. Crone, C. (1965) The permeability of brain capillaries to non-electrolytes. Acta. Physiol. Scand. 64: 407-417
9. Erickson, J. W., Gulnik, S. V., Markowitz, M. (1999) Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies. AIDS 13 (Suppl. A): S189-S204
10. Eron, J. J. (2000) HIV-protease inhibitors. Clin. Infect. Dis. 30 (Suppl. 2): S160-S170
11. Fenstermacher, J., Kaye, T. (1988) Drug "diffusion" within the brain. Ann. N. Y. Acad. Sci. 531: 29-39
12. Fenstermacher, J. D., Blasberg, R. G., Patlak, C. S. (1981) Methods for quantifying the transport of drugs across brain barrier systems. Pharmacol. Ther. 14: 217-248
13. Galinsky, R. E., Hoesterey, B. L., Anderson, B. D. (1990) Brain and cerebrospinal fluid uptake of zidovudine (AZT) in rats after intravenous injection. Life. Sci. 47: 781-788
14. Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., McMahon, D., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A., Emini, E. A., Chodakewitz, J. A. (1997) Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337: 734-739
15. Haas, D. W., Stone, J., Clough, L. A., Johnson, B., Spearman, P., Harris, V. L., Nicotera, J., Johnson, R. H., Raffanti, S., Zhong, L., Bergqwist, P., Chamberlin, S., Hoagland, V., Ju, W. D. (2000) Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection. Clin. Pharmacol. Ther. 68: 367-374
16. Habgood, M. D., Begley, D. J., Abbott, N. J. (2000) Determination of passive drug entry into central nervous system. Cell. Mol. Neurobiol. 20: 231-253
17. Hagendorff, A., Dettmers, C., Danos, P., Wetter, S., Lassau, M., Pizzulli, L., Omran, H., Bauer, T., Hartmann, A., Luderitz, B. (1994) Carotid artery stenosis and tachyarrhythmias: regional cerebral blood flow during high-rate ventricular pacing after one vessel occlusion in rats. J. Clin. Invest. 72: 775-781
18. Hamidi, M. (2006a) Simple and sensitive high-performance liquid chromatography method for the quantitation of indinavir in rat plasma and central nervous system. J. Sep. Sci. 29: 620-627
19. Hamidi, M. (2006b) Role of P-glycoprotein in tissue uptake of indinavir in rat. Life Sci. 79: 991-998
20. Hargreaves, K. M., Pardridge, W. M. (1988) Neutral amino acid transport at the human blood-brain barrier. J. Biol. Chem. 263: 19 392-19 397
21. Healy, D. P., Wilks, S. (1993) Localization of immunoreactive glutamyl aminopeptidase in rat brain. II. Distribution and correlation with angiotensin II. Brain Res. 606: 295-303
22. Johnson, B. D., Howard, A., Varsolona, R., McCauley, J., Ellison, D. K. (1999). Indinavir sulfate. In: Brittain, H. G. (ed.) Analytical profiles of drug substances and excipients. Academic Press, San Diego, pp 319-358
23. Keep, R. F., Jones, H. C. (1990) A morphometric study on the development of the lateral ventricle choroid plexus, choroid plexus capillaries and ventricular ependyma in the rat. Brain Res. Dev. Brain Res. 56: 47-53
24. Kim, R. B., Fromm, M. F., Wandel, C., Leake, B., Wood, A. J., Roden, D. M., Wilkinson, G. R. (1998) The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J. Clin. Invest. 101: 289-294
25. Krebs, F. C., Ross, H., McAllister, J., Wigdahl, B. (2000) HIV-I-associated central nervous system dysfunction. Adv. Pharmacol. Res. 19: 315-385
26. Lee, C. G., Gottesman, M. M., Cardarelli, C. O., Ramachandra, M., Jeang, K. T., Ambudkar, S. V., Pastan, I., Dey, S. (1998) HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry 37: 3594-3601
27. Lin, J. H., Chiba, M., Balani, S. K., Chen, I. W., Kwei, G. Y., Vastag, K. J., Nishime, J. A. (1996) Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor. Drug. Metab. Dispos. 24: 1111-1120
28. Martin, C., Sonnerborg, A., Svensson, J. O., Stahle, L. (1999) Indinavir-based treatment of HIV-1-infected patients: efficacy in the central nervous system. AIDS 13: 1227-1232
29. Megard, I., Garrigues, A., Orlowski, S., Jorajuria, S., Clayette, P., Ezan, E., Mabondzo, A. (2002) A co-culture-based model of human blood-brain barrier: application to active transport of indinavir and in vivo-in vitro correlation. Brain. Res. 927: 153-167
30. Ohno, K., Pettigrew, K. D., Rapoport, S. I. (1978) Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am. J. Physiol. 235: H299-H307
31. Pardridge, W. M., Triguero, D., Yang, J., Cancilla, P. A. (1990) Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier. J. Pharmacol. Exp. Ther. 253: 884-891
32. Pialoux, G., Fournier, S., Moulignier, A., Poveda, J. D., Clavel, F., Dupont, B. (1997) Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir. AIDS 11: 1302-1303
33. Renkin, E. M. (1959) Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscle. Am. J. Physiol. 197: 1205-1210
34. Sandor, P., Cox-van Put, J., deJong, W., de Wied, D. (1986) Continuous measurement of cerebral blood volume in rats with the photoelectric technique: effect of morphine and naloxone. Life Sci. 39: 1657-1665
35. Shargel, L., Yu, A. B. C. (1999) Applied biopharmaceutics and pharmacokinetics. Appleton & Lange, Stamford
36. Smith, Q. R., Ziylan, Y. Z., Robinson, P. J., Rapoport, S. I. (1988) Kinetics and distribution volumes for tracers of different sizes in the brain plasma space. Brain Res. 462: 1-9
37. Takasawa, K., Terasaki, T., Suzuki, H., Ooie, T., Sugiyama, Y. (1997a) Distributed model analysis of 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine distribution in brain tissue and cerebrospinal fluid. J. Pharmacol. Exp. Ther. 282: 1509-1517
38. Takasawa, K., Terasaki, T., Suzuki, H., Sugiyama, Y. (1997b) In vivo evidence for carrier-mediated efflux transport of 3′-azido-3′- deoxythymidine and 2′,3′-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system. J. Pharmacol. Exp. Ther. 281: 369-375
39. Tatsuta, T., Naito, M., Oh-hara, T., Sugawara, I., Tsuruo, T. (1992) Functional involvement of P-glycoprotein in blood-brain barrier. J. Biol. Chem. 267: 20 383-20 391
40. Todd, M. M., Weeks, J. B., Warner, D. S. (1992) Cerebral blood flow, blood volume, and brain tissue hematocrit during isovolemic hemodilution with hetastarch in rats. Am. J. Physiol. 263: H75-H82
41. Tsuji, A. (2000) Specific mechanisms for transporting drugs into brain. In: Begley, D. J., Bradbury, M. W., Kreuter, J. (eds) Blood-brain barrier and drug delivery to the CNS. Marcel Dekker Inc., New York, pp 121-144
42. van der Sandt, I. C., Vos, C. M., Nabulsi, L., Blom-Roosemalen, M. C., Voorwinden, H. H., de Boer, A. G., Breimer, D. D. (2001) Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood-brain barrier. AIDS 15: 483-491
43. Wang, Y., Sawchuk, R. J. (1995) Zidovudine transport in the rabbit brain during intravenous and intracerebroventricular infusion. J. Pharm. Sci. 84: 871-876
44. Waynforth, H. B., Flecknell, P. A. (1992) Experimental and surgical techniques in rat. Academic Press, London
45. Wijnholds, J., deLange, E. C., Scheffer, G. L., van den Berg, D. J., Mol, C. A., van der Valk, M., Schinkel, A. H., Scheper, R. J., Breimer, D. D., Borst, P. (2000) Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J. Clin. Invest. 105: 279-285
46. Wiley, C. A., Schrier, R. D., Nelson, J. A., Lampert, P. W., Old-stone, M. B. (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83: 7089-7093
47. Wu, D., Clement, J. G., Pardridge, W. M. (1998) Low blood-brain barrier permeability to azidothymidine (AZT), 3TC, and thymidine in the rat. Brain. Res. 791: 313-316